All In Biotech

Drug Trial Radar · NCT00797966

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Feb 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 850 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

850

Actual

Start

May 2009

Primary completion

Jun 2010

Study completion Jul 2010

Sponsor

Sponsor type
Industry
First posted
Nov 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary: To compare the efficacy of OPC-34712 to placebo as adjunctive treatment to an assigned open-label marketed antidepressant treatment (ADT)in patients who demonstrate an incomplete response to a prospective eight week trial of the same assigned open-label marketed ADT.

Conditions

  • Major Depressive Disorder

Interventions

  • OPC-34712Drug

    Tablets, Oral, 1 - 4 mg OPC-34712 variable dose once daily, 14 weeks

  • PlaceboDrug

    Tablets, Oral, 1- 4 mg OPC-34712 once daily, 14 weeks

  • ADTDrug

    Tablets, 10 - 225 mgs, dose once daily, 14 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From the End of Phase A (Week 8 Visit) to the End of Phase B (Week 14 Visit) in Montgomery Asberg Depression Rating Scale (MADRS) Total Score.Time frame: Week 8 to Week 14

Locations

50 sites in 1 country. Site status is shown where the registry gives one.

  • Pacific Clinical Research Medical Group

    Arcadia, California

  • Southwestern Research

    Beverly Hills, California

  • Synergy Escondido

    Escondido, California

  • Collaborative Neuroscience Network Inc.

    Garden Grove, California

  • Synergy Clinical Research Center

    National City, California

  • Excell Research

    Oceanside, California

  • Affiliated Research Institute

    San Diego, California

  • California Neuroscience Research Medical Group, Inc.

    Sherman Oaks, California

  • Radiant Research Center

    Denver, Colorado

  • Florida Clinical Research Center, LLC

    Bradenton, Florida

  • CNS Clinical Research Group

    Coral Springs, Florida

  • Gulfcoast Clinical Research Center

    Fort Myers, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Accurate Clinical Trials

    Kissimee, Florida

  • Clinical Neurosciences Solutions

    Orlando, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • University of South Florida College of Medicine Psychiatry Center

    Tampa, Florida

  • Janus Center

    West Palm Beach, Florida

  • Carman Research

    Smyrna, Georgia

  • Uptown Research Institute

    Chicago, Illinois

  • Midwest Center for Neurobehavioral Medicine

    Oakbrook Terrace, Illinois

  • The Davis Clinic, PC

    Indianapolis, Indiana

  • Vince & Associates Clinical Research

    Overland Park, Kansas

  • Pharmasite Research, Inc.

    Baltimore, Maryland

  • Bioscience Research

    Mount Kisco, New York

  • Eastside Comprehensive Medical Center

    New York, New York

  • Medical & Behavioral Health Research, PC

    New York, New York

  • Finger Lakes Clinical Research

    Rochester, New York

  • Carolinas HealthCare - Behavioral Heath Center

    Charlotte, North Carolina

  • NorthCoast Clinical Trials, Inc

    Beachwood, Ohio

  • Neuro-Behavioral Clinical Research, Inc

    Canton, Ohio

  • Patient Priority Clinical Sites, LLC

    Cinncinnati, Ohio

  • Midwest Clinical Research Center

    Dayton, Ohio

  • NorthStar Medical Research, LLC

    Middleburg Heights, Ohio

  • Summitt Research Network (Oregon)

    Portland, Oregon

  • Suburban Research Associates

    Media, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • USC School of Medicine- Department of Neuropsychiatry and Behavioral Science

    Columbia, South Carolina

  • Clinical Neurosciences Solutions, Inc.

    Memphis, Tennessee

  • Community Clinical Research, Inc.

    Austin, Texas

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.